Brief Acceptance and Commitment Therapy

BEHAVIORAL2 trials

Sponsors

Syracuse University, Universitas Airlangga

Conditions

Breast CancerBreast Neoplasm FemaleLocally Advanced Breast CancerLocally Advanced Breast Cancer (LABC)Treatment

Unknown Phase

Brief Acceptance and Commitment Therapy for HIV-infected At-risk Drinkers

CompletedNCT03974061

Syracuse UniversityTreatment

Start: 2019-11-01End: 2022-11-10Updated: 2026-04-01

Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to Enhance Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer

Not yet recruitingNCT07570368

Universitas AirlanggaBreast Cancer, Breast Neoplasm Female, Locally Advanced Breast Cancer +1

Start: 2026-04-28End: 2027-01-01Target: 54Updated: 2026-05-06